Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WDR63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNRD1ASP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FAM163A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF25-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C16orf87 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHV4-31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ING1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HGSNAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKFN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRMT1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TVP23C-CDRT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM234B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C18orf8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELAVL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLVAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR646HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130856 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on